Viewing nowApogril Tablet 100 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Selbion Co., Ltd.

MFDS item code 201906412 · Approved 2019.09.11
Improvement of ischemic symptoms such as chronic arterial occlusion (ulcers, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensations caused by chronic arterial occlusion, for example, Buerger's disease, atherosclerosis, and diabetic peripheral vascular disease.
As Sarpogrelate Hydrochloride, 100 mg should be taken orally three times a day after meals. Adjust dosage appropriately according to symptoms.
This medication should not be administered to patients with bleeding as it may increase the risk of bleeding. It is advisable not to use it in pregnant women or women of childbearing potential as it may affect the fetus. It contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Patients who are menstruating or have a tendency to bleed should use it cautiously as the risk of bleeding may increase. Caution should be taken when used in conjunction with anticoagulants or antiplatelet agents as it may raise the risk of bleeding. Patients with severely impaired kidney function or the elderly may experience side effects due to difficulty in drug excretion, so dose adjustment and monitoring of conditions are necessary. If any unusual symptoms such as bleeding, liver dysfunction, or skin rash occur while taking this medication, it should be discontinued immediately, and medical consultation is required. Regular blood tests to check for tendencies of bleeding or liver function status are recommended. It is preferable for pregnant or breastfeeding women not to take this medication, and if absolutely necessary, breastfeeding should be avoided. Safety in children has not been established, so its use is not recommended. Keep out of reach of children, and store in the original container to maintain quality.
Gastrointestinal bleeding (hematemesis and melena, etc.), cerebral hemorrhage, tendency for bleeding such as subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia and other blood disorders, acute hepatitis, liver dysfunction, jaundice, elevated bilirubin, AST, ALT, ALP, γ-GTP, LDH levels indicating liver dysfunction and jaundice
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be at room temperature between 1 to 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Selbion Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.